BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

663 related articles for article (PubMed ID: 25027687)

  • 61. Preoperative Leucocytosis, Thrombocytosis and Anemia as Potential Prognostic Factors in Non-metastatic Renal Cell Carcinoma.
    Hutterer GC; Krieger D; Mrsic E; Pohlmann K; Bezan A; Stojakovic T; Pummer K; Zigeuner R; Pichler M
    Anticancer Res; 2015 Jun; 35(6):3463-9. PubMed ID: 26026111
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Preoperative Anemia as an Independent Prognostic Indicator of Papillary Renal Cell Carcinoma.
    Huang J; Feldman AS; Dong L; Cornejo K; Liu Q; Dahl DM; Wu S; Blute ML; Huang Y; Wu CL
    Clin Genitourin Cancer; 2015 Oct; 13(5):e353-60. PubMed ID: 25998556
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Validation of a postoperative prognostic model consisting of tumor microvascular invasion, size, and grade to predict disease-free and cancer-specific survival of patients with surgically resected renal cell carcinoma.
    May M; Brookman-Amissah S; Kendel F; Knoll N; Roigas J; Hoschke B; Miller K; Gilfrich C; Pflanz S; Gralla O
    Int J Urol; 2009 Jul; 16(7):616-21. PubMed ID: 19456988
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A novel prognostic model for patients with sarcomatoid renal cell carcinoma.
    Zhang BY; Thompson RH; Lohse CM; Leibovich BC; Boorjian SA; Cheville JC; Costello BA
    BJU Int; 2015 Mar; 115(3):405-11. PubMed ID: 24730416
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prognostic role of D-dimer for in-hospital and 1-year mortality in exacerbations of COPD.
    Hu G; Wu Y; Zhou Y; Wu Z; Wei L; Li Y; Peng G; Liang W; Ran P
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2729-2736. PubMed ID: 27843309
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Pathological prognostic indicators in renal cell carcinoma].
    Rey Rey J; León Ramírez D; López García S; Fernández Vázquez P; Benavente Delgado J; Ojea Calvo A
    Actas Urol Esp; 2010 Jan; 34(1):71-7. PubMed ID: 20223135
    [TBL] [Abstract][Full Text] [Related]  

  • 67. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
    Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K
    Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma.
    Sengupta S; Lohse CM; Cheville JC; Leibovich BC; Thompson RH; Webster WS; Frank I; Zincke H; Blute ML; Kwon ED
    Cancer; 2006 Jan; 106(2):304-12. PubMed ID: 16353202
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prognostic significance of indeterminate lung nodules in renal cell carcinoma.
    Xu R; Horick N; McGovern FJ; Dahl DM; Feldman AS; Blute ML; Olumi AF; Michaelson MD
    Urol Oncol; 2014 Apr; 32(3):355-61. PubMed ID: 24397994
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prognostic role of cell cycle and proliferative biomarkers in patients with clear cell renal cell carcinoma.
    Gayed BA; Youssef RF; Bagrodia A; Kapur P; Darwish OM; Krabbe LM; Sagalowsky A; Lotan Y; Margulis V
    J Urol; 2013 Nov; 190(5):1662-7. PubMed ID: 23792148
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
    Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Preoperative Chronic Kidney Disease Status is an Independent Prognostic Factor in Patients with Renal Cell Carcinoma.
    Kim YW; Kim WT; Yun SJ; Lee SC; Kim WJ; Ha YS; Park YH; Kang SH; Hong SH; Kwon TG; Byun SS; Kwak C; Kim YJ
    Ann Surg Oncol; 2015 Nov; 22(12):4098-103. PubMed ID: 25851339
    [TBL] [Abstract][Full Text] [Related]  

  • 73. GALNT4 predicts clinical outcome in patients with clear cell renal cell carcinoma.
    Liu Y; Liu W; Xu L; Liu H; Zhang W; Zhu Y; Xu J; Gu J
    J Urol; 2014 Nov; 192(5):1534-41. PubMed ID: 24769034
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Multicenter Study of Controlling Nutritional Status (CONUT) Score as a Prognostic Factor in Patients With HIV-Related Renal Cell Carcinoma.
    Xue W; Zhang Y; Wang H; Zhang Y; Hu X
    Front Immunol; 2021; 12():778746. PubMed ID: 34917092
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prognostic significance of pretreatment plasma D-dimer levels in patients with spinal chordoma: a retrospective cohort study.
    Li B; Zhang H; Zhou P; Yang J; Wei H; Yang X; Yang C; Wu Z; Xiao J
    Eur Spine J; 2019 Jun; 28(6):1480-1490. PubMed ID: 30684054
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical significance of plasma D-dimer levels and serum VEGF levels in patients with hepatocellular carcinoma.
    Tseng CS; Lo HW; Chen PH; Chuang WL; Juan CC; Ker CG
    Hepatogastroenterology; 2004; 51(59):1454-8. PubMed ID: 15362775
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pathological characteristics and prognostic effect of peritumoral capsule penetration in renal cell carcinoma after tumor enucleation.
    Minervini A; Rosaria Raspollini M; Tuccio A; Di Cristofano C; Siena G; Salvi M; Vittori G; Sebastianelli A; Lapini A; Serni S; Carini M
    Urol Oncol; 2014 Jan; 32(1):50.e15-22. PubMed ID: 24239462
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Papillary renal cell carcinoma: correlation of tumor grade and histologic characteristics with clinical outcome.
    Cornejo KM; Dong F; Zhou AG; Wu CL; Young RH; Braaten K; Sadow PM; Nielsen GP; Oliva E
    Hum Pathol; 2015 Oct; 46(10):1411-7. PubMed ID: 26297250
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prognostic significance of elevated D-dimer for survival in patients with sarcoma.
    Raj SD; Zhou X; Bueso-Ramos CE; Ravi V; Patel S; Benjamin RS; Vadhan-Raj S
    Am J Clin Oncol; 2012 Oct; 35(5):462-7. PubMed ID: 21654313
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
    Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
    BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.